Dacarbazine (DTIC-Dome)

Dacarbazine is an approved anti-cancer drug, which is used frequently in combination with other drugs for the treatment of metastatic melanoma and Hodgkin’s disease.

It comes as powder that is reconstituted into a liquid for intravenous injection. It suppresses the bone marrow, causing leukopenia and thrombocytopenia. Other common side-effects include nausea, vomiting and hair loss.

Dacarbazine is manufactured by Bayer under the tradename DTIC-Dome.

Up a level
Back to contents
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.